{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:27:15Z","timestamp":1780410435767,"version":"3.54.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jinf.2023.03.011","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T16:03:13Z","timestamp":1678550593000},"page":"453-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Inflammation burden score in multidrug-resistant HIV-1 infection"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6548-3427","authenticated-orcid":false,"given":"Tommaso","family":"Clemente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Caccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia Carla","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bandera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0344-6281","authenticated-orcid":false,"given":"Maurizio","family":"Zazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Mercedes","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cinque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9656-7217","authenticated-orcid":false,"given":"Vincenzo","family":"Spagnuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2023.03.011_bib1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/archinternmed.2009.472","article-title":"Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years","volume":"170","author":"Lodwick","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jinf.2023.03.011_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106252","article-title":"Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database","volume":"57","author":"Lombardi","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2023.03.011_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1473-3099(11)70248-1","article-title":"Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study","volume":"12","author":"Costagliola","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2023.03.011_bib4","doi-asserted-by":"crossref","first-page":"ofaa456","DOI":"10.1093\/ofid\/ofaa456","article-title":"Burden of disease in PWH harboring a multidrug-resistant virus: data from the PRESTIGIO Registry","volume":"7","author":"Galli","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jinf.2023.03.011_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081355","article-title":"Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada","volume":"8","author":"Samji","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2023.03.011_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/QAI.0000000000000825","article-title":"Long-term mortality in HIV-infected individuals 50 years or older: a nationwide, population-based cohort study","volume":"71","author":"Legarth","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 2","key":"10.1016\/j.jinf.2023.03.011_bib7","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/infdis\/jiw275","article-title":"Immunologic biomarkers, morbidity, and mortality in treated HIV infection","volume":"214","author":"Hunt","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2023.03.011_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/infdis\/jit147","article-title":"Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy","volume":"208","author":"Erlandson","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2023.03.011_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144312","article-title":"Elevated biomarkers of inflammation and coagulation in patients with HIV are associated with higher Framingham and VACS Risk Index Scores","volume":"10","author":"Mooney","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2023.03.011_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/QAI.0000000000001881","article-title":"Inflammation relates to poorer complex motor performance among adults living with HIV on suppressive antiretroviral therapy","volume":"80","author":"Montoya","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2023.03.011_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.jinf.2023.03.011_bib12","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/infdis\/jiu238","article-title":"Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection","volume":"210","author":"Hunt","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2023.03.011_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/QAI.0000000000000954","article-title":"Do biomarkers of inflammation, monocyte activation, and altered coagulation explain excess mortality between HIV infected and uninfected people","volume":"72","author":"So-Armah","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2023.03.011_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152588","article-title":"D-dimer levels before HIV seroconversion remain elevated even after viral suppression and are associated with an increased risk of Non-AIDS events","volume":"11","author":"Freiberg","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2023.03.011_bib15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1089\/jir.2005.25.702","article-title":"Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection","volume":"25","author":"Widney","year":"2005","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jinf.2023.03.011_bib16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/cid\/ciw683","article-title":"Persistent, albeit reduced, chronic inflammation in persons starting antiretroviral therapy in acute HIV infection","volume":"64","author":"Sereti","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2023.03.011_bib17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/hiv.12270","article-title":"The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV-1 infection","volume":"16","author":"O'Halloran","year":"2015","journal-title":"HIV Med"},{"key":"10.1016\/j.jinf.2023.03.011_bib18","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/infdis\/jir060","article-title":"Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy","volume":"203","author":"Hunt","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2023.03.011_bib19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/cid\/civ840","article-title":"CD8 T-cell expansion and inflammation linked to CMV coinfection in ART-treated HIV infection","volume":"62","author":"Freeman","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2023.03.011_bib20","doi-asserted-by":"crossref","first-page":"11407","DOI":"10.1128\/JVI.01211-09","article-title":"High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment","volume":"83","author":"Gonzalez","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.jinf.2023.03.011_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000852","article-title":"Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation","volume":"6","author":"Nazli","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jinf.2023.03.011_bib22","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jinf.2023.03.011_bib23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/aid.2018.0252","article-title":"Fungal translocation is associated with immune activation and systemic inflammation in treated HIV","volume":"35","author":"Weiner","year":"2019","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.jinf.2023.03.011_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/CMR.00050-12","article-title":"Microbial translocation in the pathogenesis of HIV infection and AIDS","volume":"26","author":"Marchetti","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jinf.2023.03.011_bib25","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jinf.2023.03.011_bib26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00002030-200203080-00002","article-title":"CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention","volume":"16","author":"Leng","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2023.03.011_bib27","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1084\/jem.20081398","article-title":"Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection","volume":"205","author":"Jones","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jinf.2023.03.011_bib28","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1097\/QAD.0000000000000407","article-title":"Simplification to atazanavir\/ritonavir monotherapy for HIV-1 treated individuals on virological suppression: 48-week efficacy and safety results","volume":"28","author":"Castagna","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2023.03.011_bib29","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/jac\/dkw031","article-title":"Atazanavir\/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized tria","volume":"71","author":"Galli","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2023.03.011_bib30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/cid\/cis406","article-title":"HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation","volume":"55","author":"Armah","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2023.03.011_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154829","article-title":"Thermal stability of cytokines: a\u00a0review","volume":"125","author":"Simpson","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.jinf.2023.03.011_bib32","article-title":"Cytokines: from clinical significance to quantification","volume":"8","author":"Liu","year":"2021","journal-title":"Adv Sci"},{"key":"10.1016\/j.jinf.2023.03.011_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/1471-2334-13-399","article-title":"Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study","volume":"13","author":"Armah","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2023.03.011_bib34","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1038\/s41598-018-24446-4","article-title":"Cardiovascular markers of inflammation and serum lipid levels in HIV-infected patients with undetectable viremia","volume":"8","author":"Vi\u0161kovi\u0107","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jinf.2023.03.011_bib35","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/QAD.0000000000000184","article-title":"Inflammatory cytokines and mortality in a cohort of HIV-infected adults with alcohol problems","volume":"28","author":"Fuster","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2023.03.011_bib36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2249.1992.tb05854.x","article-title":"The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value","volume":"90","author":"Levacher","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jinf.2023.03.011_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clim.2018.06.001","article-title":"Residual T cell activation and skewed CD8+ T cell memory differentiation despite antiretroviral therapy-induced HIV suppression","volume":"195","author":"Tanko","year":"2018","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jinf.2023.03.011_bib38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1468-1293.2007.00528.x","article-title":"CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy","volume":"9","author":"Steel","year":"2008","journal-title":"HIV Med"},{"issue":"4","key":"10.1016\/j.jinf.2023.03.011_bib39","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/CMR.00015-16","article-title":"Total HIV-1 D.N.A., a marker of viral reservoir dynamics with clinical implications","volume":"29","author":"Avettand-F\u00e8no\u00ebl","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jinf.2023.03.011_bib40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/COH.0000000000000230","article-title":"Residual inflammation and viral reservoirs: alliance against an HIV cure","volume":"11","author":"Massanella","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.jinf.2023.03.011_bib41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/QAD.0000000000002063","article-title":"Do people living with HIV experience greater age advancement than their HIV-negative counterparts","volume":"33","author":"De Francesco","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2023.03.011_bib42","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s001340050877","article-title":"Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome","volume":"25","author":"Strutz","year":"1999","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jinf.2023.03.011_bib43","first-page":"263","article-title":"Endogenous endotoxin-core antibody (EndoCAb) as a marker of endotoxin exposure and a prognostic indicator: a review","volume":"392","author":"Barclay","year":"1995","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.jinf.2023.03.011_bib44","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1182\/blood-2005-11-013383","article-title":"Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection","volume":"108","author":"Titanji","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2023.03.011_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084185","article-title":"B cell responses to HIV antigen are a potent correlate of viremia in HIV-1 infection and improve with PD-1 blockade","volume":"8","author":"Nicholas","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2023.03.011_bib46","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/cid\/ciz212","article-title":"Circulating (1\u21923)-\u03b2-D-glucan is associated with immune activation during human immunodeficiency virus infection","volume":"70","author":"Mehraj","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2023.03.011_bib47","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jinf.2023.03.011_bib48","first-page":"21","article-title":"Anti-inflammatory drugs as anticancer agents","author":"Zappavigna","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jinf.2023.03.011_bib49","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jinf.2023.03.011_bib50","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/ni1515","article-title":"Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction","volume":"8","author":"Kaufmann","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jinf.2023.03.011_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008886","article-title":"Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease","volume":"5","author":"Naeger","year":"2010","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.jinf.2023.03.011_bib52","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/QAD.0b013e32834640e6","article-title":"Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients","volume":"25","author":"Appay","year":"2011","journal-title":"AIDS"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445323001391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445323001391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:36:00Z","timestamp":1759008960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445323001391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0163445323001391"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2023.03.011","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation burden score in multidrug-resistant HIV-1 infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2023.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}